SMAD2 and cystic fibrosis: Previous studies have indicated that TGF- βR, a major receptor in the TGF-β/Smad2/3 pathway in renal interstitial fibrosis, can be modified with CF [38], while WNT, a receptor of the WNT/β-catenin pathway, is also a glycoprotein [39].